Literature DB >> 24201375

The ATP-binding cassette transporter-2 (ABCA2) regulates esterification of plasma membrane cholesterol by modulation of sphingolipid metabolism.

Warren Davis1.   

Abstract

The ATP-binding cassette transporters are a large family (~48 genes divided into seven families A-G) of proteins that utilize the energy of ATP-hydrolysis to pump substrates across lipid bilayers against a concentration gradient. The ABC "A" subfamily is comprised of 13 members and transport sterols, phospholipids and bile acids. ABCA2 is the most abundant ABC transporter in human and rodent brain with highest expression in oligodendrocytes, although it is also expressed in neurons. Several groups have studied a possible connection between ABCA2 and Alzheimer's disease as well as early atherosclerosis. ABCA2 expression levels have been associated with changes in cholesterol and sphingolipid metabolism. In this paper, we hypothesized that ABCA2 expression level may regulate esterification of plasma membrane-derived cholesterol by modulation of sphingolipid metabolism. ABCA2 overexpression in N2a neuroblastoma cells was associated with an altered bilayer distribution of the sphingolipid ceramide that inhibited acylCoA:cholesterol acyltransferase (ACAT) activity and cholesterol esterification. In contrast, depletion of endogenous ABCA2 in the rat schwannoma cell line D6P2T increased esterification of plasma membrane cholesterol following treatment with exogenous bacterial sphingomyelinase. These findings suggest that control of ABCA2 expression level may be a key locus of regulation for esterification of plasma membrane-derived cholesterol through modulation of sphingolipid metabolism.
© 2013.

Entities:  

Keywords:  ABCA2; Ceramide; Cholesterol; Esterification; Sphingomyelin; Transporter

Mesh:

Substances:

Year:  2013        PMID: 24201375      PMCID: PMC4437569          DOI: 10.1016/j.bbalip.2013.10.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  43 in total

Review 1.  ABC proteins: key molecules for lipid homeostasis.

Authors:  Kei Takahashi; Yasuhisa Kimura; Koh Nagata; Akitsugu Yamamoto; Michinori Matsuo; Kazumitsu Ueda
Journal:  Med Mol Morphol       Date:  2005-03       Impact factor: 2.309

2.  Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease.

Authors:  M Axel Wollmer; Elisabeth Kapaki; Martin Hersberger; Jörg Muntwyler; Fabienne Brunner; Magdalini Tsolaki; Hiroyasu Akatsu; Kenji Kosaka; Makoto Michikawa; Dimitra Molyva; Giorgos P Paraskevas; Dieter Lütjohann; Arnold von Eckardstein; Christoph Hock; Roger M Nitsch; Andreas Papassotiropoulos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-07-05       Impact factor: 3.568

3.  Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells.

Authors:  Woojin S Kim; Gilles J Guillemin; Elias N Glaros; Chai K Lim; Brett Garner
Journal:  Neuroreport       Date:  2006-06-26       Impact factor: 1.837

4.  Rapid flip-flop of phospholipids in endoplasmic reticulum membranes studied by a stopped-flow approach.

Authors:  U Marx; G Lassmann; H G Holzhütter; D Wüstner; P Müller; A Höhlig; J Kubelt; A Herrmann
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

5.  Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.

Authors:  Laura Calpe-Berdiel; Ying Zhao; Marjo de Graauw; Dan Ye; Peter J van Santbrink; A Mieke Mommaas; Amanda Foks; Martine Bot; Illiana Meurs; Johan Kuiper; Jody T Mack; Miranda Van Eck; Kenneth D Tew; Theo J C van Berkel
Journal:  Atherosclerosis       Date:  2012-06-12       Impact factor: 5.162

6.  Rapid transbilayer movement of ceramides in phospholipid vesicles and in human erythrocytes.

Authors:  Iván López-Montero; Nicolas Rodriguez; Sophie Cribier; Antje Pohl; Marisela Vélez; Philippe F Devaux
Journal:  J Biol Chem       Date:  2005-05-09       Impact factor: 5.157

Review 7.  The ABC transporters in lipid flux and atherosclerosis.

Authors:  Iryna Voloshyna; Allison B Reiss
Journal:  Prog Lipid Res       Date:  2011-02-23       Impact factor: 16.195

8.  Down-regulation of the ATP-binding cassette transporter 2 (Abca2) reduces amyloid-β production by altering Nicastrin maturation and intracellular localization.

Authors:  Vasiliki Michaki; Francesc X Guix; Krist'l Vennekens; Sebastian Munck; Colin Dingwall; John B Davis; Danyelle M Townsend; Kenneth D Tew; Fabian Feiguin; Bart De Strooper; Carlos G Dotti; Tina Wahle
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

9.  A lipid-specific toxin reveals heterogeneity of sphingomyelin-containing membranes.

Authors:  Reiko Ishitsuka; Akiko Yamaji-Hasegawa; Asami Makino; Yoshio Hirabayashi; Toshihide Kobayashi
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

Review 10.  Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases.

Authors:  Jean E Vance
Journal:  Dis Model Mech       Date:  2012-10-12       Impact factor: 5.758

View more
  8 in total

1.  The ATP-Binding Cassette Transporter-2 (ABCA2) Overexpression Modulates Sphingosine Levels and Transcription of the Amyloid Precursor Protein (APP) Gene.

Authors:  Warren Davis
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

Review 2.  ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target.

Authors:  Warren Davis; Kenneth D Tew
Journal:  Biochem Pharmacol       Date:  2017-12-06       Impact factor: 5.858

3.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

Review 4.  The role of ATP-binding cassette transporter A2 in childhood acute lymphoblastic leukemia multidrug resistance.

Authors:  N Aberuyi; S Rahgozar; A Moafi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-07-20

5.  Longitudinal Phenotypes Improve Genotype Association for Hyperketonemia in Dairy Cattle.

Authors:  Francisco A Leal Yepes; Daryl V Nydam; Sabine Mann; Luciano Caixeta; Jessica A A McArt; Thomas R Overton; Joseph J Wakshlag; Heather J Huson
Journal:  Animals (Basel)       Date:  2019-12-01       Impact factor: 2.752

6.  Involvement of ABC-transporters and acyltransferase 1 in intracellular cholesterol-mediated autophagy in bovine alveolar macrophages in response to the Bacillus Calmette-Guerin (BCG) infection.

Authors:  Jinrui Xu; Yanbing Zhou; Yi Yang; Cuiping Lv; Xiaoming Liu; Yujiong Wang
Journal:  BMC Immunol       Date:  2020-05-12       Impact factor: 3.615

7.  Quantitative Systems Pharmacology Model for Alzheimer Disease Indicates Targeting Sphingolipid Dysregulation as Potential Treatment Option.

Authors:  Diana Clausznitzer; Cesar Pichardo-Almarza; Ana Lucia Relo; Jeroen van Bergeijk; Elizabeth van der Kam; Loic Laplanche; Neil Benson; Marjoleen Nijsen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-10-08

Review 8.  Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases.

Authors:  Oscar Teijido; Ramón Cacabelos
Journal:  Int J Mol Sci       Date:  2018-10-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.